Upon drug treatment, CHOP induction enhances apoptosis through transactivation of DR5 in human carcinoma (Yamaguchi and Wang 2004), prostate cancer (Shiraishi et al. 2005), pancreatic cancer (Abdelrahim et al. 2006), and lung cancer (Lin et al. 2008). This evidence concerns the gene DDIT3 and lung carcinoma.